omniture
Samsung Biologics Co. Ltd.

Latest News

Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance

INCHEON, South Korea, Sept. 17, 2023 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced t...

2023-09-18 07:57 1191

Samsung Biologics appoints new leadership to oversee quality and regulatory affairs

- Distinguished industry leaders with extensive track records in quality assurance and regulatory a...

2023-08-24 07:59 1379

Samsung Biologics Reports Second Quarter 2023 Financial Results

* Recorded Q2'23 consolidated revenue of KRW 866.2 billion * Recorded Q2'23 consolidated operati...

2023-07-26 15:23 1497

Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility

INCHEON, South Korea, July 18, 2023 /PRNewswire/ -- Samsung Biologics (KRX: 207940), a global contr...

2023-07-18 19:00 1504

Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025

- Marking the first phase of the company's second Bio Campus, Plant 5 is expected to have shortest ...

2023-06-06 19:00 1920

Samsung Biologics Reports First Quarter 2023 Financial Results

* Recorded Q1'23 consolidated revenue of KRW 720.9 billion. * Recorded Q1'23 consolidated operat...

2023-04-24 14:51 1963

Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion

* The company plans to begin construction in the first half of 2023 and commence operations in 20...

2023-03-17 19:25 2839

Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results

* Q4'22 consolidated revenue of KRW 965.5 billion and Q4'22 operating profit ofKRW 312.8 billion....

2023-01-27 14:52 3328

Samsung Biologics receives the Terra Carta Seal in recognition of the company's commitment to creating a sustainable future

* Samsung Biologics is one of 19 companies to have been awarded the 2022 Terra Carta Seal. * Th...

2023-01-11 08:01 2062

Samsung Biologics Reports Third Quarter 2022 Financial Results

* Recorded consolidated revenue of KRW 873 billion in Q3'22 * Recorded consolidated operating pr...

2022-10-27 07:35 1821

Samsung Biologics obtains three global ISO certifications

* Receives accreditation for information security management system, information security in clou...

2022-10-13 19:00 1229

Samsung Biologics unlocks additional capacity for production at its newest Plant 4

* Plant 4 commences GMP operations within just 23 months since groundbreaking, as planned * Par...

2022-10-11 19:00 1172

Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022

* Two distinctive platforms will streamline the antibody development process. * With an advanced ...

2022-09-29 19:00 1082

Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts

* Rising from last year's ranking, the company's united effort and dedication to integrating sust...

2022-09-28 19:00 1119

GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine

* GreenLight's messenger RNA production process is transferable to large-scale equipment and CMO ...

2022-08-01 21:00 1997

Samsung Biologics Reports Second Quarter 2022 Financial Results

* Released consolidated financial position of the company based on its full acquisition of Samsun...

2022-07-27 14:43 1732

Samsung Biologics to purchase land for its second Bio Campus

* Acquires additional land, sized 357,366㎡ valued at KRW 426 billion, for Bio Campus 2 * Plans ...

2022-07-18 19:00 1364

'Sustainable CDMO' Samsung Biologics releases 2022 ESG Report

* Aims to build an eco-friendly business environment and achieve net zero GHG emissions in its op...

2022-07-11 19:00 1776

Samsung Biologics Reports First Quarter 2022 Financial Results

* Q1'22 revenue of KRW 511.3 billion increased 96% compared to Q1'21. * Q1'22 operating profit o...

2022-04-27 14:42 1572

Samsung Biologics completes full acquisition of Samsung Bioepis

* Samsung Biologics has now fully acquired Samsung Bioepis, as a wholly owned subsidiary * Firs...

2022-04-20 14:45 1661
12345